Product Detail
(-)-Tabersonine-D2
Tabersonine Stable Isotopes
Stock Status: Enquire
Live
For Research & Analytical Purposes. Not for Personal use.
Category
Stable Isotopes
API Family
Tabersonine
Storage
Refer MSDS for complete information.
Hazard Information
Refer MSDS for complete information.
(-)-Tabersonine-D2 Product Information
(-)-Tabersonine-D2 is listed under Stable Isotopes. It is associated with Tabersonine and is intended for analytical research, quality control and pharmaceutical reference standard applications. The product is supplied by Clearsynth under CAT No. CS-T-103793.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight, stock enquiry details and supporting documentation.
Technical Data
Product Name
(-)-Tabersonine-D2
CAS No.
4429-63-4(unlabelled)
CAT No.
CS-T-103793
Molecular Formula
C₂₁H₂₂D₂N₂O₂
Molecular Weight
338.44
Category
API Family
Storage Condition
Refer MSDS for complete information.
SMILES
CC[C@]12CC(C(OC)=O)=C3[C@]4(C5=CC([2H])=CC([2H])=C5N3)[C@@]1([H])N(CC=C2)CC4
IUPAC Name
(5α,12R,19α)-2,3,6,7-Tetradehydroaspidospermidine-3-carboxylic Acid Methyl Ester-D2; 3a-Ethyl-3a,4,6,11,12,13a-hexahydro-1H-indolizino[8,1-cd]carbazole-5-carboxylic Acid Methyl Ester-D2; Tabersonine-D2; Tabersonin-D2;
Hazard Compound
Refer MSDS for complete information.
Description
Overview
(-)-Tabersonine-D2 is an intermediate used in the synthesis of Apovincaminic Acid-d4 (A729252), which is the main labelled metabolite of Vinpocetine (V332502), a vasodilator cerebral.
Synonyms
(5α,12R,19α)-2,3,6,7-Tetradehydroaspidospermidine-3-carboxylic Acid Methyl Ester-D2; 3a-Ethyl-3a,4,6,11,12,13a-hexahydro-1H-indolizino[8,1-cd]carbazole-5-carboxylic Acid Methyl Ester-D2; Tabersonine-D2; Tabersonin-D2;
Application Notes
(-)-Tabersonine-D2 is an intermediate used in the synthesis of Apovincaminic Acid-d4 (A729252), which is the main labelled metabolite of Vinpocetine (V332502), a vasodilator cerebral.
References
Miskolczi, P., et al.: Eur. J. Clin. Pharmacol., 33, 185 (1987), Kiss, B., et al.: Eur. J. Pharmacol., 209, 109 (1991), Stephenson, D., et al.: J. Neurosci., 15, 5263 (1995),